Detalhe da pesquisa
1.
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
N Engl J Med
; 389(1): 33-44, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407001
2.
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study.
Lancet
; 402(10402): 641-654, 2023 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37295445
3.
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024.
J Natl Compr Canc Netw
; 22(3): 175-204, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626800
4.
Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy.
Eur J Nucl Med Mol Imaging
; 50(11): 3349-3353, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300573
5.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Lancet
; 397(10277): 892-901, 2021 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676628
6.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.
J Natl Compr Canc Netw
; 19(11): 1218-1230, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781267
7.
Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database.
Cancer
; 126(4): 808-813, 2020 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721140
8.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
9.
Complexities in the diagnosis of large B-cell lymphomas, classic Hodgkin lymphomas and overlapping peripheral T-cell lymphomas simplified: An evidence-based guide.
Ann Diagn Pathol
; 46: 151534, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32473554
10.
Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma.
Br J Haematol
; 184(4): 524-535, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575016
11.
CLL14 Trial: Fixed-Duration Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve CLL.
Oncology (Williston Park)
; 33(11)2019 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769861
12.
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting.
JCO Oncol Pract
; : OP2300630, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626366
13.
Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study.
Blood Adv
; 8(9): 2085-2093, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38315043
14.
SOHO State of the Art Updates and Next Questions: New Targetable Pathways in Chronic Lymphocytic Leukemia.
Clin Lymphoma Myeloma Leuk
; 23(4): 232-237, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754692
15.
Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell Neoplasms.
Arch Pathol Lab Med
; 147(8): 940-948, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36445717
16.
Current and emerging treatment options in primary mediastinal B-cell lymphoma.
Ther Adv Hematol
; 12: 20406207211048959, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34659697
17.
The role of acalabrutinib in adults with chronic lymphocytic leukemia.
Ther Adv Hematol
; 12: 2040620721990553, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33613932
18.
Toci or not toci: innovations in the diagnosis, prevention, and early management of cytokine release syndrome.
Leuk Lymphoma
; 62(11): 2600-2611, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34151714
19.
Survival after autologous versus allogeneic transplantation in patients with relapsed and refractory Hodgkin lymphoma.
Leuk Lymphoma
; 62(10): 2408-2415, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33988071
20.
Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.
Clin Lymphoma Myeloma Leuk
; 21(4): 246-256.e2, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33288485